We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 2 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 5 actions collected · 4 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 02. 10. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 12. 05. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 09. 05. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 07. 23. | HC Wainwright & Co. | — | Initiate coverage | — → Buy | — | HC Wainwright & Co.: Buy |
| 2019. 11. 18. | Morgan Stanley | — | Downgrade | Overweight → Equal-Weight | — | Morgan Stanley: Overweight → Equal-Weight |
Past rating changes by firm, agreement/divergence within the sector, and what target changes mean.